Overview

the Hypertrophic Scar Prevention of BMT101.

Status:
Recruiting
Trial end date:
2022-08-31
Target enrollment:
Participant gender:
Summary
An Independent Evaluator-Blind, Dose-Escalation, Untreated-Controlled, Within-Subject, Phase 2a Therapeutic Exploratory Clinical Trial
Phase:
Phase 2
Details
Lead Sponsor:
Hugel